IDHWT GBM

Clinical trials for IDHWT GBM explained in plain language.

Never miss a new study

Get alerted when new IDHWT GBM trials appear

Sign up with your email to follow new studies for IDHWT GBM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug combo aims to fight returning brain tumors

Disease control Not yet recruiting

This early-stage trial tests a new drug called STAR-001 combined with the blood pressure medication spironolactone in about 68 people whose glioblastoma has returned after initial treatment. The goal is to see if the combination is safe and can shrink tumors. Participants receive…

Matched conditions: IDHWT GBM

Phase: PHASE1, PHASE2 • Sponsor: Starlight Therapeutics Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:02 UTC

IDHWT GBM

Get alerted when new IDHWT GBM trials appear

New drug combo aims to fight returning brain tumors